4//SEC Filing
Bronstein Ben 4
Accession 0000899243-21-023007
CIK 0001341235other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:44 PM ET
Size
10.5 KB
Accession
0000899243-21-023007
Insider Transaction Report
Form 4
Bronstein Ben
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-08+875→ 875 totalExercise: $12.97Exp: 2031-06-07→ Common Stock (875 underlying) - Award
Stock Option (Right to Buy)
2021-06-08+933→ 933 totalExercise: $12.97Exp: 2031-06-07→ Common Stock (933 underlying) - Award
Stock Option (Right to Buy)
2021-06-08+13,534→ 13,534 totalExercise: $12.97Exp: 2031-06-07→ Common Stock (13,534 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001604458
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:44 PM ET
- Size
- 10.5 KB